SCHEDULE 13D

Company

abrdn Life Sciences Investors

Filed

January 4, 2011

Accession Number

0000921895-11-000004

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →